FDA Approves Multiple Sclerosis Drug Lemtrada by Genzyme, Comes with Boxed Warning Lemtrada, a drug manufactured by Genzyme for the treatment of MS has been approved for sale in the U.S. The drug, however, will come with a boxed warning. by Anu Passary